GenSight will participate to the Cell & Gene Meeting on the Mediterranean, a virtual conference organized by the Alliance of Regenerative Medicine (ARM) held from April 6 to 9, 2021, and will host partnering meetings.

Bernard Gilly, co-Founder and CEO of GenSight Biologics, will be a speaker at a roundtable on “Cell and gene therapies for ophthalmologic diseases”.

Dr Magali Taiel, Chief Medical Officer, will present the company.

The roundtable and the GenSight presentation will be pre-recorded and available on-demand for attendees to watch at their convenience.